Corteva

Corteva, Inc. (NYSE: CTVA) stands as a global leader in agricultural science and innovation, providing advanced seed genetics, crop protection solutions, and digital agriculture technologies to farmers in over 110 countries. With annual revenues of approximately $17 billion and 22,000 employees worldwide, Corteva combines cutting-edge research capabilities with deep agricultural expertise to help farmers sustainably produce food for a growing global population. The company operates through two primary segments—Seed and Crop Protection—offering an integrated portfolio of products and services that maximize farm productivity while promoting environmental stewardship.

Corteva's formation in 2019 represents the culmination of over a century of agricultural innovation from two iconic American companies. The company was created through the 2017 merger of Dow Chemical and DuPont, which combined the agricultural divisions of both companies including DuPont Pioneer (the world's leading seed company) and Dow AgroSciences. This union brought together DuPont's 90+ year heritage in seed development with Dow's expertise in crop protection chemistry, creating a comprehensive agriculture platform. Corteva spun off as an independent public company on June 1, 2019, enabling focused investment in agricultural innovation and agile response to farmer needs.

The company's Seed segment represents a cornerstone of modern agriculture, built on the Pioneer brand's legendary reputation for high-performance genetics. Corteva develops and supplies advanced germplasm and traits that produce optimum yields across corn, soybeans, wheat, and other major crops. The seed portfolio includes proprietary genetics developed through both traditional breeding and advanced biotechnology, serving farmers in over 90 countries through the Pioneer flagship brand and regional brands like Brevant, Dairyland, and NuTech. The Crop Protection segment offers a comprehensive portfolio of fungicides, herbicides, insecticides, and biologicals that protect crops from weeds, disease, and pests, with notable products including Enlist herbicide technology and an expanding biologicals business targeting $1 billion in annual revenue.

Corteva invests approximately 8% of revenue—nearly $4 million daily—in research and development, maintaining one of the industry's most robust innovation pipelines. The company operates state-of-the-art research facilities globally, including Centers for Seed Applied Technologies and advanced breeding stations. This R&D commitment has produced breakthrough innovations in gene editing, biologicals, and precision agriculture, with plans to launch 20 new products with over $200 million revenue potential during 2024-2025. Looking ahead, Corteva announced in October 2025 a strategic plan to separate into two independent public companies by late 2026—one focused on crop protection and biologicals, the other on advanced genetics and emerging technologies—positioning both entities for accelerated growth in their respective markets.